Anticancer and immunostimulatory effects of nucleoprotein fraction of Bacillus subtilis 7025 culture medium filtrate

Experimental Oncology

Volumn 25, Issue 2, 2003, Pages 119-123

  Shlyakhovenko, V A ^a   Olishevsky, S V ^a   Kozak, V V ^a   Yanish, Y V ^a   Rybalko, S L ^b  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

^b INSTITUTE OF HYDROBIOLOGY   (Ukraine)

Author keywords

Antitumor autovaccine; Bacillus subtilis 7025; Bacterial DNA; CpG DNA; Glycopeptide; Interferons; Murine Erlich's carcinoma; NK cells; Nucleoprotein fraction; Vesicular stomatitis virus

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; GAMMA INTERFERON; GLYCOPEPTIDE ANTICANCER AUTOVACCINE; IMMUNOSTIMULATING AGENT; NUCLEOPROTEIN; NUCLEOPROTEIN FRACTION; UNCLASSIFIED DRUG; NUCLEOPROTEIN BACILLUS SUBTILIS 7025;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; IMMUNOSTIMULATION; LEUKOCYTE; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; BACILLUS SUBTILIS; CULTURE MEDIUM;

EID: 0042524441     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Ballas ZK, Rasmussen WL, Krieg AM. Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996; 157: 1840-5.
2. Coley WB. The treatment of malignant tumors by repeated inoculations of erysipelas: with a report of ten original cases. Clin Orthop 1893; 262: 3-6.
3. Espinoza-Delgano I. Cancer vaccines. The Oncologist 2002; 7: 20-33.
4. Filchakov FV, Malinovskaya TP, Grinevich Yu A, Bliznyuk IA. Microscopic variant of the method for detection of cytotoxic activity of lymphocytes. Labor Diagnost 1998; 13: 28-30 (In Ukrainian).
5. Hafner M, Zawatzky R, Hirtreiter C, Buurman WA, Echtenacher B, Hehlgans T, Männel D. Antimetastatic effect of CpG DNA mediated by type I IFN. Cancer Res 2001; 61: 5523-8.
6. Hennge UR, Benninghoff B, Ruzicka T, Goos M. Topical immunomodulators - progress towards treating inflammation, infection, and cancer. Lancet Infect Diseases 2001; 1: 189-98.
7. Ho M, Enders J. An inhibitory of viral activity appearing in infected cell cultures. Proc Nat Acad Sci 1959; 45: 385-9.
8. Kadowaki N, Liu YJ. Natural type I interferon-producing cells as a link between innate and adaptive immunity. Hum Immunol 2002; 63: 1126-32.
9. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-61.
10. Krieg AM. CpG motifs in bacterial DNA and their immune effects. Ann Rev Immunol 2002; 20: 709-60.
11. Krieg AM. The role of CpG motifs in innate immunity. Curr Opin Immunol 2000; 12: 35-43.
12. Krieg AM, Hartmann G, Yi AK. Mechanism of action of CpG DNA. Curr Top Microbiol Immunol 2000; 247: 1-21.
13. Kroll J. Inhibition tumor cell DNA-synthesis by Yoshida ascites fluid fractions isolated by precipitation with polyethylenglycol. In: Biology of the cancer cell. Letnansky K, ed. Kugler Publications: Amsterdam, 1980; 434 p.
14. Kuzovkova NA. Colorimetric evaluation on natural killer activity. Immunol 1991; 4: 59-61 (In Russian).
15. Lapach SN, Chubenko AV, Babich PN. Statistical methods with using Excel in medical and biological investigations. Kiev: Morion, 2001; 408 p (In Russian).
16. Levicky DO. Calcium and biological membranes. Moskow: Vysshaya Shkola, 1990; 124 p (In Russian).
17. Lymphocytes. A practical approach. Klaus GGB, ed. Moscow: Mir, 1990; 395 p (In Russian).
18. Potebnya GP, Semernikov VA, Lisovenko GS, Khutornyy SV, Kolesnyk OO, et al. New stage in the production of anticancer vaccines. In: The directions and perspectives of experimental oncology in Ukraine. Chekhun VF, ed. Kyiv: DIA, 2001; p. 104-14 (In Ukrainian).
19. Sun S, Zhang X, Tough DF, Sprent J. Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med 1998; 188: 2335-42.
20. Shimada S, Yano O, Tokunaga T. In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG. Jpn J Cancer Res 1986; 77: 808-16.
21. Shlyakhovenko VA. Modern trends in cancer vaccinotherapy. Exp Oncol 2000; 3: 99-109 (In Russian).
22. Shlyakhovenko VA, Potebnya GP, Mosiyenko VS, Zagoruyko LI, Kozak VV, et al. New technology of engineering of polyvalent anticancer vaccines. In: The directions and perspectives of experimental oncology in Ukraine. Chekhun VF, ed. Kyiv: DIA, 2001; p. 115-22 (In Ukrainian).
23. Shpakova AP, Pavlova KS, Bulycheva TI. MTT-colorimetric method for measuring the cytotoxic activity of human natural killer cells. Clin Labor Diagnost 2000; 2: 20-3 (In Russian).
24. Stacey KJ, Sester DP, Sweet MJ, Hume DA. Macrophage activation by immunostimulatory DNA. Curr Top Microbiol Immunol 2000; 247: 41-58
25. Vasilakos JP, Smith RM, Gibson SJ, et al. Adjuvant activities of immune response modifier R-848: comparison with CpG ODN. Cell Immunol 2000; 204: 64-74.
26. Weiner GJ, Liu H-M, Wooldridge JE, Dahle CE, Krieg AM. Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization. Proc Natl Acad Sci USA 1997; 94: 10833-7.
27. Weiner GJ. The immunobiology and clinical potential of immunostimulatory CpG oligodeoxynucleotides. J Leukocyte Biol 2000; 68: 455-63.
28. Wiemann B, Starnes CO. Coley's toxins, tumor necrosis factor and cancer research: a historical perspective. Pharmacol Ther 1994; 64: 529-35.
29. Yamamoto S, Kuramoto E, Shimada S, Tokunaga T. In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from Mycobacterium bovis BCG. Jpn J Cancer Res 1988; 7: 866-73.
30. Yamamoto S, Yamamoto T, Shimada T, Kuramoto E, Yano O, Kataoka T, Tokunaga T. DNA from bacteria, but not vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microb Immunol 1992; 36: 983.
31. Zatula DG. Similarity of microbial antigens and tumor cells. Kiev: Naukova dumka, 1982; 247 p (In Russian).
32. Zatula DG. Microbiological aspects of study of malignant growth. Kiev: Naukova dumka, 1976; 239 p (In Russian).